News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
191,922 Results
Type
Article (10220)
Company Profile (22)
Press Release (181680)
Multimedia
Podcasts (26)
Webinars (7)
Section
Business (71460)
Career Advice (334)
Deals (11482)
Drug Delivery (35)
Drug Development (23293)
Employer Resources (41)
FDA (4065)
Job Trends (4171)
News (107866)
Policy (7484)
Tag
Academia (613)
Accelerated approval (11)
Adcomms (9)
Allergies (38)
Alliances (11787)
ALS (54)
Alzheimer's disease (473)
Antibody-drug conjugate (ADC) (89)
Approvals (4155)
Artificial intelligence (158)
Autoimmune disease (51)
Automation (3)
Bankruptcy (119)
Best Places to Work (3336)
BIOSECURE Act (10)
Biosimilars (64)
Biotechnology (19)
Bladder cancer (37)
Brain cancer (14)
Breast cancer (145)
Cancer (1467)
Cardiovascular disease (118)
Career advice (295)
Career pathing (7)
CAR-T (76)
CDC (5)
Cell therapy (241)
Cervical cancer (5)
Clinical research (20291)
Collaboration (418)
Company closure (1)
Compensation (239)
Complete response letters (30)
COVID-19 (832)
CRISPR (28)
C-suite (239)
Cystic fibrosis (36)
Data (1925)
Denatured (7)
Depression (60)
Diabetes (143)
Diagnostics (1734)
Digital health (15)
Diversity (5)
Diversity, equity & inclusion (12)
Drug discovery (62)
Drug pricing (54)
Drug shortages (7)
Duchenne muscular dystrophy (68)
Earnings (43566)
Editorial (26)
Employer branding (5)
Employer resources (38)
Events (21702)
Executive appointments (317)
FDA (5036)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (13)
Funding (817)
Gene editing (78)
Generative AI (15)
Gene therapy (207)
GLP-1 (322)
Government (858)
Guidances (244)
Healthcare (5045)
HIV (10)
Huntington's disease (16)
IgA nephropathy (34)
Immunology and inflammation (90)
Immuno-oncology (15)
Indications (29)
Infectious disease (901)
Inflammatory bowel disease (46)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (84)
Interviews (46)
IPO (6231)
IRA (19)
Job creations (932)
Job search strategy (256)
JPM (24)
Kidney cancer (2)
Labor market (34)
Layoffs (208)
Leadership (5)
Legal (1514)
Liver cancer (36)
Longevity (2)
Lung cancer (261)
Lymphoma (153)
Machine learning (15)
Management (9)
Manufacturing (197)
MASH (37)
Medical device (3834)
Medtech (3856)
Mergers & acquisitions (5608)
Metabolic disorders (390)
Multiple sclerosis (45)
NASH (4)
Neurodegenerative disease (93)
Neuropsychiatric disorders (32)
Neuroscience (856)
Neurotech (1)
NextGen: Class of 2026 (1924)
Non-profit (839)
Now hiring (8)
Obesity (200)
Opinion (91)
Ovarian cancer (45)
Pain (41)
Pancreatic cancer (93)
Parkinson's disease (57)
Partnered (11)
Patents (123)
Patient recruitment (143)
Peanut (15)
People (15285)
Pharmaceutical (8)
Pharmacy benefit managers (3)
Phase 1 (6149)
Phase 2 (9058)
Phase 3 (7224)
Pipeline (2208)
Policy (70)
Postmarket research (519)
Preclinical (2202)
Press Release (9)
Prostate cancer (60)
Psychedelics (13)
Radiopharmaceuticals (53)
Rare diseases (261)
Real estate (1365)
Recruiting (22)
Regulatory (6306)
Reports (11)
Research institute (512)
Resumes & cover letters (44)
Rett syndrome (8)
RNA editing (6)
RSV (23)
Schizophrenia (56)
Series A (191)
Series B (141)
Service/supplier (1)
Sickle cell disease (14)
Special edition (8)
Spinal muscular atrophy (57)
Sponsored (5)
Startups (2404)
Stomach cancer (4)
Supply chain (27)
Tariffs (15)
The Weekly (19)
Vaccines (309)
Venture capital (88)
Weight loss (120)
Women's health (27)
Worklife (5)
Date
Today (30)
Last 7 days (130)
Last 30 days (554)
Last 365 days (9292)
2026 (787)
2025 (9449)
2024 (11110)
2023 (12709)
2022 (16523)
2021 (16925)
2020 (15530)
2019 (12772)
2018 (9843)
2017 (9366)
2016 (8065)
2015 (9418)
2014 (6917)
2013 (5385)
2012 (5801)
2011 (6371)
2010 (6134)
Location
Africa (191)
Alabama (25)
Alaska (2)
Arizona (60)
Arkansas (6)
Asia (12514)
Australia (1343)
California (3613)
Canada (1275)
China (346)
Colorado (137)
Connecticut (154)
Delaware (68)
Europe (23890)
Florida (435)
Georgia (104)
Hawaii (2)
Idaho (12)
Illinois (229)
India (18)
Indiana (152)
Iowa (3)
Japan (203)
Kansas (44)
Kentucky (9)
Louisiana (11)
Maine (42)
Maryland (542)
Massachusetts (2296)
Michigan (108)
Minnesota (158)
Mississippi (3)
Missouri (63)
Montana (8)
Nebraska (5)
Nevada (25)
New Hampshire (23)
New Jersey (1076)
New Mexico (8)
New York (937)
North Carolina (407)
Northern California (1737)
Ohio (120)
Oklahoma (5)
Oregon (8)
Pennsylvania (607)
Puerto Rico (8)
Rhode Island (6)
South America (273)
South Carolina (14)
Southern California (1513)
Tennessee (39)
Texas (488)
United States (11974)
Utah (94)
Virginia (42)
Washington D.C. (10)
Washington State (184)
West Virginia (3)
Wisconsin (23)
Wyoming (2)
191,922 Results for "third rock ventures".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Stealth Third Rock Ventures Backed Company Selects Parse Biosciences GigaLab to Build Largest TCR Atlas for Common Autoimmune Disease
November 13, 2025
·
2 min read
Press Releases
Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 17, 2025
·
12 min read
Press Releases
Scholar Rock to Report Third Quarter 2025 Financial Results on November 14, 2025
October 24, 2025
·
2 min read
Press Releases
Scholar Rock Highlights 2026 Strategic Priorities
January 12, 2026
·
12 min read
Spinal muscular atrophy
Much Maligned Manufacturing Site Trips Up Scholar Rock’s Spinal Muscular Atrophy Drug
In its rejection letter, the FDA flagged problems at a third-party fill-finish site owned by Novo Nordisk. Issues at this site have previously been investigated by the regulator.
September 23, 2025
·
2 min read
·
Tristan Manalac
Business
Third Rock Ventures Expands Senior Team with Seasoned Biotech Executives
Third Rock Ventures announced today that it has expanded its senior team with the addition and promotion of several industry leaders.
January 25, 2024
·
5 min read
Obesity
Scholar Rock Jumps on Weight Loss Data for Zepbound/Repurposed Antibody Combo
In combination with Eli Lilly’s tirzepatide, marketed as Zepbound for obesity, Scholar Rock’s monolonal antibody helped patients lose the same amount of weight as patients on tirzepatide alone while preserving more muscle mass.
June 18, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Scholar Rock to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
2 min read
Press Releases
Scholar Rock to Present at Upcoming December 2025 Investor Conferences
November 19, 2025
·
2 min read
Press Releases
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 16, 2026
January 19, 2026
·
3 min read
1 of 19,193
Next
